LON:CTEC ConvaTec Group (CTEC) Share Price, News & Analysis → Incredible Opportunity to Retire FAST! (From Crypto 101 Media) (Ad) Free CTEC Stock Alerts GBX 283.60 +1.20 (+0.42%) (As of 05:36 AM ET) Add Compare Share Share Today's Range 283▼ 284.8050-Day Range 234.60▼ 293.5852-Week Range 195.10▼ 295.20Volume2.90 million shsAverage Volume5.29 million shsMarket Capitalization£5.81 billionP/E Ratio5,672.00Dividend Yield1.76%Price TargetGBX 307.17 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsDividendHeadlinesInsider TradesStock AnalysisAnalyst ForecastsChartCompetitorsDividendHeadlinesInsider Trades Get ConvaTec Group alerts: Email Address ConvaTec Group MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside8.3% UpsideGBX 307.17 Price TargetShort InterestN/ADividend StrengthWeakBased on Four FactorsSustainabilityN/ANews SentimentN/AInsider TradingN/AProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.0.25 out of 5 stars 1.5 Analyst's Opinion Consensus RatingConvaTec Group has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 6 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoverageConvaTec Group has only been the subject of 2 research reports in the past 90 days. Previous Next N/A Short Interest Short InterestThere is no current short interest data available for CTEC. Previous Next 0.8 Dividend Strength Dividend YieldConvaTec Group pays a meaningful dividend of 1.69%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthConvaTec Group does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of ConvaTec Group is 10,000.00%. Payout ratios above 75% are not desirable because they may not be sustainable. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for CTEC. Previous Next 0.6 News and Social Media Coverage Search Interest2 people have searched for CTEC on MarketBeat in the last 30 days. Previous Next 3.3 Company Ownership Insider Buying vs. Insider SellingIn the past three months, ConvaTec Group insiders have not sold or bought any company stock.Percentage Held by Insiders20.20% of the stock of ConvaTec Group is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions66.70% of the stock of ConvaTec Group is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of ConvaTec Group is 5,672.00, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 143.54.Price to Earnings Ratio vs. SectorThe P/E ratio of ConvaTec Group is 5,672.00, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 239.64.Price to Earnings Growth RatioConvaTec Group has a PEG Ratio of 2.40. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioConvaTec Group has a P/B Ratio of 3.42. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Crypto 101 MediaIncredible Opportunity to Retire FAST!A brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market.Click here to get instant access to the guide About ConvaTec Group Stock (LON:CTEC)ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, and bladder cancer. In addition, the company offers continence care products and services for people with urinary continence issues related to spinal cord injuries, multiple sclerosis, spina bifida, and other causes, as well as critical care devices and products used in intensive care units and hospital settings. Further, it provides infusion care solutions comprising disposable infusion sets for diabetes insulin pumps, or for pumps used in continuous subcutaneous infusion treatments for conditions such as parkinson's disease. The company sells its products to pharmacies, hospitals, and other acute and post-acute healthcare service providers directly or through distributors and wholesalers. It serves a range of customers, including healthcare providers, patients, and manufacturers. ConvaTec Group PLC was founded in 1978 and is headquartered in London, the United Kingdom.Read More CTEC Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CTEC Stock News HeadlinesMarch 14, 2024 | finanznachrichten.deConvatec Group PLC: Director/ PDMR Shareholding -2-March 12, 2024 | markets.businessinsider.comConvatec Group PLC: Director/ PDMR ShareholdingApril 23, 2024 | Traders Agency (Ad)top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.March 8, 2024 | lse.co.ukLondon midday: FTSE drifts lower ahead of payrollsMarch 8, 2024 | msn.comU.K. shares lower at close of trade; Investing.com United Kingdom 100 down 0.47%March 6, 2024 | msn.comU.K. shares higher at close of trade; Investing.com United Kingdom 100 up 0.40%March 6, 2024 | marketwatch.comConvaTec Group PLC FY EPS 6.3cFebruary 23, 2024 | investing.comConvaTec Group PLC (CTEC)April 23, 2024 | Traders Agency (Ad)top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.February 9, 2024 | lse.co.ukLondon midday: FTSE nudges up as investors pause for breathJanuary 31, 2024 | uk.finance.yahoo.comConvatec Group Plc (CTEC.L)January 17, 2024 | msn.comU.K. shares lower at close of trade; Investing.com United Kingdom 100 down 1.50%August 31, 2023 | finanznachrichten.deConvatec Group PLC: TR-1 Notification of Major HoldingsAugust 22, 2023 | finance.yahoo.comIs There An Opportunity With ConvaTec Group PLC's (LON:CTEC) 32% Undervaluation?August 4, 2023 | finance.yahoo.comConvaTec Group First Half 2023 Earnings: EPS Misses ExpectationsJuly 24, 2023 | finanznachrichten.deConvatec Group PLC: HOL-Holding(s) in CompanyJuly 10, 2023 | finance.yahoo.comConvaTec Group (LON:CTEC) Hasn't Managed To Accelerate Its ReturnsJune 9, 2023 | msn.comJP Morgan Cazenove Reiterates ConvaTec Group (LSE:CTEC) Overweight RecommendationJune 7, 2023 | finance.yahoo.comCTEC.L - ConvaTec Group PLCMay 31, 2023 | uk.finance.yahoo.comConvatec Group PLC: Total Voting RightsMay 20, 2023 | msn.comBarclays Reiterates ConvaTec Group (LSE:CTEC) Overweight RecommendationMay 18, 2023 | uk.finance.yahoo.comConvatec Group PLC: Result of AGMApril 19, 2023 | marketwatch.com30 Technology's Clinically Validated Antimicrobial Nitric Oxide Platform Acquired by Convatec Group Plc for Several ApplicationsMarch 28, 2023 | uk.finance.yahoo.com2 cheap shares I’d buy as the FTSE 100 slidesMarch 26, 2023 | finance.yahoo.comConvaTec Group (LON:CTEC) shareholders YoY returns are lagging the company's 23% three-year earnings growthMarch 22, 2023 | markets.businessinsider.comConvatec Group PLC: Annual Report and Accounts 2022 and Notice of AGMMarch 2, 2023 | finance.yahoo.comFDA clears first placental extracellular matrix medical device for management of second-degree burnsSee More Headlines Receive CTEC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for ConvaTec Group and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/28/2020Today4/22/2024Ex-Dividend for 5/23 Dividend4/25/2024Dividend Payable5/23/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Medical Instruments & Supplies Sub-IndustryN/A Current SymbolLON:CTEC CUSIPN/A CIKN/A Webwww.convatecgroup.com Phone44 11 8952 8100FaxN/AEmployees10,136Year FoundedN/APrice Target and Rating Average Stock Price TargetGBX 307.17 High Stock Price TargetGBX 323 Low Stock Price TargetGBX 300 Potential Upside/Downside+8.8%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage6 Analysts Profitability EPS (Most Recent Fiscal Year)GBX 0.05 Trailing P/E Ratio5,648.00 Forward P/E Ratio22.54 P/E Growth2.4Net Income£130.30 million Net Margins6.08% Pretax MarginN/A Return on Equity7.89% Return on Assets4.79% Debt Debt-to-Equity Ratio77.53 Current Ratio1.62 Quick Ratio0.96 Sales & Book Value Annual Sales£2.14 billion Price / Sales2.71 Cash FlowGBX 16.60 per share Price / Cash Flow17.01 Book ValueGBX 83 per share Price / Book3.40Miscellaneous Outstanding Shares2,050,000,000Free FloatN/AMarket Cap£5.79 billion OptionableNot Optionable Beta0.55 Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report Key ExecutivesMr. Karim Bitar (Age 59)CEO & Director Comp: $2.97MMr. Jonathan Peter Mason (Age 60)Group CFO & Director Comp: $1.59MMr. John HallerExecutive VP and Chief Quality & Operations OfficerDr. Divakar Ramakrishnan Ph.D.Executive VP, Chief Technology Officer and Head of Research & DevelopmentMs. Kate PostansVice President of Investor Relations & Corporate CommunicationsMs. Evelyn Douglas J.D.Executive VP, Chief of Corporate Strategy & Business Development and General CounselMs. Moyra WithycombeInterim Chief People OfficerMs. Kjersti Grimsrud Biotechnology (Age 63)M.Sc., President & COO of Infusion Care Mr. David ShepherdPresident & COO of Global Advanced Wound CareMr. Seth R. Segel (Age 55)President and COO of Continence Care & Home Services Group More ExecutivesKey CompetitorsDechra PharmaceuticalsLON:DPHHikma PharmaceuticalsLON:HIKMediclinic InternationalLON:MDCBTGLON:BTGSmith & NephewLON:SNView All CompetitorsInsidersKarim BitarSold 429,441 sharesTotal: £92.76 M ($216.00/share)View All Insider Transactions CTEC Stock Analysis - Frequently Asked Questions Should I buy or sell ConvaTec Group stock right now? 6 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for ConvaTec Group in the last year. There are currently 6 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" CTEC shares. View CTEC analyst ratings or view top-rated stocks. What is ConvaTec Group's stock price target for 2024? 6 brokers have issued 12-month price targets for ConvaTec Group's shares. Their CTEC share price targets range from GBX 300 to GBX 323. On average, they predict the company's stock price to reach GBX 307.17 in the next year. This suggests a possible upside of 8.3% from the stock's current price. View analysts price targets for CTEC or view top-rated stocks among Wall Street analysts. How have CTEC shares performed in 2024? ConvaTec Group's stock was trading at GBX 244.20 on January 1st, 2024. Since then, CTEC shares have increased by 16.1% and is now trading at GBX 283.60. View the best growth stocks for 2024 here. How were ConvaTec Group's earnings last quarter? ConvaTec Group PLC (LON:CTEC) issued its quarterly earnings data on Friday, February, 28th. The company reported $12.00 earnings per share for the quarter, missing analysts' consensus estimates of $12.70 by $0.70. ConvaTec Group had a trailing twelve-month return on equity of 7.89% and a net margin of 6.08%. How often does ConvaTec Group pay dividends? What is the dividend yield for ConvaTec Group? ConvaTec Group declared a dividend on Wednesday, March 6th. Investors of record on Thursday, April 25th will be paid a dividend of GBX 0.04 per share on Thursday, May 23rd. This represents a dividend yield of 1.39%. The ex-dividend date is Thursday, April 25th. This is a boost from the stock's previous dividend of GBX 0.02. The official announcement can be seen at this link. Read our dividend analysis for CTEC. Is ConvaTec Group a good dividend stock? ConvaTec Group (LON:CTEC) pays an annual dividend of GBX 5 per share and currently has a dividend yield of 1.69%. The dividend payout ratio is 10,000.00%. Payout ratios above 75% are not desirable because they may not be sustainable. Read our dividend analysis for CTEC. What other stocks do shareholders of ConvaTec Group own? Based on aggregate information from My MarketBeat watchlists, some companies that other ConvaTec Group investors own include EnQuest (ENQ), Centamin (CEY), Oxford Biomedica (OXB), Bristol-Myers Squibb (BMY), Andalas Energy and Power (ADL), AFR.L (AFR), CBTX (CBTX), Genel Energy (GENL), Premier Oil (PMO) and Playtech (PTEC). How do I buy shares of ConvaTec Group? Shares of CTEC stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. This page (LON:CTEC) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingThe A.I. story nobody is telling you (Read ASAP)TradeSmithHealthcare Takes A Big Step Forward With The Help Of AIThe Bull Reporttop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap Profits[Shocking] Elon Musk’s Plan To End BanksCrypto 101 MediaUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ConvaTec Group PLC Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.